InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,667.20
(
0.64%
)
US TECH 100
19,854.40
(
0.04%
)
Dow Jones
40,954.48
(
1.85%
)
Brent Oil
83.22
(
-1.33%
)
Bitcoin
65,112.01
(
0.40%
)

Replies to post #1282 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1282 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DewDiligence

01/17/16 8:30 PM

#1283 RE: NY1972 #1282

Why is GT3 cirrhotics excluded in EXPEDITION-1?

GT3 cirrhotics are the most difficult patients to treat for most DAA regimens. ABT-493/ABT-530 will probably require a third drug to get a satisfactory SVR rate in this patient group.